Lower extremity deep venous thrombosis: Evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism - Preliminary experience

Radiology

Volumn 242, Issue 3, 2007, Pages 873-881

  Li, Wei ^a,c   Salanitri, John ^a,c   Tutton, Sean ^a,c   Dunkle, Eugene E ^a   Schneider, Joseph R ^b,c   Caprini, Joseph A ^b,c   Pierchala, Linda N ^a   Jacobs, Paula M ^d   Edelman, Robert R ^a,c  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b Division of Cardiothoracic Surgery   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Advanced Magnetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FERUMOXYTOL;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; LEG THROMBOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE VENOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; CONTRAST MEDIA; FEMALE; FERROSOFERRIC OXIDE; HUMANS; IMAGE ENHANCEMENT; LEG; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS;

EID: 33847175868     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2423052101     Document Type: Article

References (22)

1. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet 1969;2:230-232.
2. Lewis BD. The peripheral veins. In: Bumack CM, Wilson SR, Charboneau JW, eds: Diagnostic ultrasound. 3rd ed. St. Louis, Mo: Elsevier Mosby, 2005;1019-1035.
3. Subramaniam RM, Heath R, Chou T, Cox K, Davis G, Swarbrick M. Deep venous thrombosis: withholding anticoagulation therapy after negative complete lower limb US findings. Radiology 2005;237:348-352.
4. Cornuz J, Pearson SD, Polak JF. Deep venous thrombosis: complete lower extremity venous US evaluation in patients without known risk factors-outcome study. Radiology 1999;211:637-641.
5. Spritzer CE, Arata MA, Freed KS. Isolated pelvic deep venous thrombosis: relative frequency as detected with MR imaging. Radiology 2001;219:521-525.
6. Carpenter JP, Holland GA, Baum RA, Owen RS, Carpenter JT, Cope C. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg 1993;18:734-741.
7. Kanne JP, Lalani TA. Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism. Circulation 2004;109(12 suppl 1): I15-I21.
8. Laissy JP, Cinqualbre A, Loshkajian A, et al. Assessment of deep venous thrombosis in the lower limbs and pelvis: MR venography versus duplex Doppler sonography. AJR Am J Roentgenol 1996;167:971-975.
9. Bjørnerud A, Johansson L. The utility of superparamagnetic contrast agents in MRI: theoretical consideration and applications in the cardiovascular system. NMR Biomed 2004;17:465-477.
10. Prince MR, Grist TM, Debatin JF. 3D contrast MR angiography, 3rd ed. New York, NY: Springer, 2003; 233-246.
11. Hoffmann U, Loewe C, Bernhard C, et al. MRA of the lower extremities in patients with pulmonary embolism using a blood pool contrast agent: initial experience. J Magn Reson Imaging 2002;15:429-437.
12. Larsson EM, Sundén P, Olsson CG, et al. MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage. AJR Am J Roentgenol 2003;180:227-232.
13. Schmitz SA, Albrecht T, Wolf KJ. MR angiography with superparamagnetic iron oxide: feasibility study. Radiology 1999;213:603-607.
14. Schmitz SA, Winterhalter S, Schiffler S, et al. USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 2001;221:237-243.
15. Kroft LJ, de Roos A. Blood pool contrast agents for cardiovascular MR imaging. J Magn Reson Imaging 1999;10:395-403.
16. Prasad PV, Pierchala L, Chen Q, et al. Preliminary evaluation of code 7228 as an iron oxide based blood pool contrast, agent for CE-MRA [abstr]. In: Proceedings of the Eleventh Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society For Magnetic Resonance in Medicine, 2003; 1338.
17. Jacobs PM, Shenouda M. A Phase 1 Pharmacokinetics and safety study of ferumoxytol: a new blood pool and macrophage specific superparamagnetic iron oxide MR contrast agent [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, III: Radiological Society of North America, 2003; 249.
18. Prince MR, Zhang HL, Chabra SG, Jacobs P, Wang Y. A pilot investigation of new superparamagnetic iron oxide (ferumoxytol) as a contrast agent for cardiovascular MRI. J X-Ray Sci Technol 2003;11:231-240.
19. Vu AT, Li W, Pierchala L, Tutton SM, Prasad PV, Edelman RR. Robust multi-slice black blood imaging using a novel blood pool contrast agent [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, III: Radiological Society of North America, 2003; 311.
20. Mai VM, Tutton S, Li W, et al. Submillimeter spatial resolution contrast-enhanced MRA of the carotid arteries using ferumoxytol in humans [abstr]. In: Proceedings of the Thirteenth Meeting of the international Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2005; 2580.
21. Ersoy H, Jacobs P, Kent CK, Prince MR. Blood pool MR angiography of aortic stent-graft endoleak. AJR Am J Roentgenol 2004;182:1181-1186.
22. Li W, Tutton S, Vu AT, et al. First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent. J Magn Reson Imaging 2005;21:46-52.